Possible role of transforming growth factor-β in relapsing-remitting multiple sclerosis

Neurological Research

Volumn 19, Issue 6, 1997, Pages 599-600

  Carrieri, P B ^a   Provitera, V ^a   Bruno, R ^a   Perrella, M ^b   Tartaglia, G ^b   Busto, A ^b   Perrella, O ^b,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^c NONE   (Italy)

Author keywords

Cerebrospinal fluid; Multiple sclerosis; SICAM 1; TGF

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CORRELATION FUNCTION; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PROTEIN EXPRESSION; RELAPSE; REMISSION;

EID: 0031469301     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.1997.11740866     Document Type: Article

References (12)

1. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992; 10: 153-193
2. Raine CS, Traugott U. Further lymphocyte characterization in the central nervous system in multiple sclerosis. Annu NY Acad Sci 1984; 436: 163-175
3. Olsson T. Immunology of multiple sclerosis. Curr Opin Neurol Neurosurg 1992; 5: 195-203
4. Benveniste EN. Inflammatory cytokines within the central nervous system: Sources, function, and mechanisms of action. Am J Physiol 1992; 263: 1-16
5. Kobayashi Y, Kawai K, Honda H, Tomida S, Niimi N, Tamatani T, Miyasaka M, Yoshikai Y. Antibodies against leukocyte function-associated antigen-1 and against intercellular adhesion molecule-1 together suppress the progression of experimental allergic encephalomyelitis. Cell Immunol 1995; 164: 295-305
6. Dhanani S, Huang M, Wang J, Dubinett SM. Interferon-alfa inhibits murine macrophage transforming growth factor beta mRNA expression. Inflammation 1994; 18: 301-309
7. Poser CM, Paty DW, Schenberg L, McDonald WI, Davis FA, Ebers GC, Johnson WP, Sibley WA, Silberberg DA, Tourtelotte WW. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-233
8. Carrieri PB, Soscia E, Iacovitti B, Pellicano M, D'Antonio A, Provitera V, Perrella O. Soluble Interleukin-2 receptor and soluble CD8 molecules in cerebrospinal fluid and serum of patients with multiple sclerosis. Eur Cytokine Netw 1992; 3: 495-498
9. Carrieri PB, Maiorino A, Provitera V, Perrella A, Perrella O. Evaluation of interleukin 10 and interferon-alfa in the cerebrospinal fluid and serum of patients with multiple sclerosis. Eur J Neurol 1996; 3: 544-547
10. Chantry D, Turner M, Abney E, Feldmann M. Modulation of cytokine production by transforming growth factor-β-1. J Immunol 1989; 142: 4295-4300
11. Fox FE, Oleszack EL, Chen PF, Platsoucas CD. Human hibridoma-derived suppressor factor 160 and transforming growth factor beta are different molecules. Lymph Cytokine Res 1992; 11: 307-315
12. Espevik T, Figari IS, Shalaby MR, Lackides GA, Ewis GD, Shepard HM. Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J Exp Med 1987; 166: 571-576